CVE-2024-26272

Liferay Portal and Liferay DXP Vulnerable to Cross-Site Request Forgery (CSRF) via the Content Page Editor

Cross-site request forgery (CSRF) vulnerability in the content page editor in Liferay Portal 7.3.2 through 7.4.3.107, and Liferay DXP 2023.Q4.0 through 2023.Q4.2, 2023.Q3.1 through 2023.Q3.5, 7.4 GA through update 92 and 7.3 GA through update 35 allows remote attackers to (1) change user passwords, (2) shut down the server, (3) execute arbitrary code in the scripting console, (4) and perform other administrative actions via the p_l_back_url parameter.

A victim's authenticated browser session is used to submit forged requests to an application that cannot distinguish them from legitimate ones. Typical impact: state-changing actions performed as the victim without their consent.

CVE-2024-26272 has a CVSS score of 8.8 (High). The vector is network-reachable, no privileges required, and user interaction required. A CVSS score reflects the worst-case severity of the vulnerability, not your specific exposure. Whether this affects your application depends on whether the vulnerable code is present and reachable in your environment. A fixed version is available (7.4.3.108, 2023.Q4.3, 2023.Q3.6, 7.3u36, 7.4u93); upgrading removes the vulnerable code path.

Kodem intelligence

Already deployed Kodem?

1. What is CVE-2024-26272? CVE-2024-26272 is a high-severity cross-site request forgery (CSRF) vulnerability in com.liferay.portal:release.portal.bom (maven), affecting versions >= 7.3.2, < 7.4.3.108. It is fixed in 7.4.3.108, 2023.Q4.3, 2023.Q3.6, 7.3u36, 7.4u93. A victim's authenticated browser session is used to submit forged requests to an application that cannot distinguish them from legitimate ones.
2. How severe is CVE-2024-26272? CVE-2024-26272 has a CVSS score of 8.8 (High). This score reflects the worst-case severity of the vulnerability, not your specific exposure. Whether it represents real risk in your environment depends on whether the vulnerable code is present and reachable.
3. Which packages are affected by CVE-2024-26272?
   • com.liferay.portal:release.portal.bom (maven) (versions >= 7.3.2, < 7.4.3.108)
   • com.liferay.portal:release.dxp.bom (maven) (versions >= 2023.Q4.0, < 2023.Q4.3)
4. Is there a fix for CVE-2024-26272? Yes. CVE-2024-26272 is fixed in 7.4.3.108, 2023.Q4.3, 2023.Q3.6, 7.3u36, 7.4u93. Upgrade to this version or later.
5. Is CVE-2024-26272 exploitable, and should I be worried? Whether CVE-2024-26272 is exploitable in your environment depends on whether the vulnerable code is present and reachable. A CVSS score is a worst-case rating; it does not account for your specific deployment, configuration, or usage patterns. Kodem, an Intelligent Application Security platform, uses runtime intelligence to show which vulnerabilities actually execute in production, so you can focus on the ones that represent real risk. Get a demo
6. What actually determines whether CVE-2024-26272 is exploitable, and how bad it is? Exploitability and impact are not fixed properties of a CVE. They depend on runtime truth: whether the vulnerable code is present, reachable, and actually executes in your application. A high CVSS score on a dependency that never runs is not the same as real risk. Kodem, an Intelligent Application Security platform, uses runtime intelligence to reveal which vulnerabilities actually execute in production, so teams prioritize the ones that genuinely matter.
7. How do I fix CVE-2024-26272?
   • Upgrade com.liferay.portal:release.portal.bom to 7.4.3.108 or later
   • Upgrade com.liferay.portal:release.dxp.bom to 2023.Q4.3 or later
   • Upgrade com.liferay.portal:release.dxp.bom to 2023.Q3.6 or later
   • Upgrade com.liferay.portal:release.dxp.bom to 7.3u36 or later
   • Upgrade com.liferay.portal:release.dxp.bom to 7.4u93 or later

Other vulnerabilities in com.liferay.portal:release.portal.bom